DE60316339D1 - N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones als antimikrobielle mittel - Google Patents

N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones als antimikrobielle mittel

Info

Publication number
DE60316339D1
DE60316339D1 DE60316339T DE60316339T DE60316339D1 DE 60316339 D1 DE60316339 D1 DE 60316339D1 DE 60316339 T DE60316339 T DE 60316339T DE 60316339 T DE60316339 T DE 60316339T DE 60316339 D1 DE60316339 D1 DE 60316339D1
Authority
DE
Germany
Prior art keywords
methyleneamino
pyridones
sulphonyl
hydroxy
antimicrobial agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60316339T
Other languages
English (en)
Other versions
DE60316339T2 (de
Inventor
Namal Chithranga Warshakoon
Rodney Dean Bush
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Co LLC
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE60316339D1 publication Critical patent/DE60316339D1/de
Application granted granted Critical
Publication of DE60316339T2 publication Critical patent/DE60316339T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60316339T 2002-11-09 2003-11-07 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones als antimikrobielle mittel Expired - Lifetime DE60316339T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42507102P 2002-11-09 2002-11-09
US425071P 2002-11-09
PCT/US2003/035623 WO2004043928A2 (en) 2002-11-09 2003-11-07 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents

Publications (2)

Publication Number Publication Date
DE60316339D1 true DE60316339D1 (de) 2007-10-25
DE60316339T2 DE60316339T2 (de) 2008-06-05

Family

ID=32312927

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60316339T Expired - Lifetime DE60316339T2 (de) 2002-11-09 2003-11-07 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones als antimikrobielle mittel

Country Status (25)

Country Link
US (3) US6946479B2 (de)
EP (1) EP1558580B1 (de)
JP (1) JP4327730B2 (de)
KR (2) KR20050055793A (de)
CN (1) CN1708482A (de)
AT (1) ATE372986T1 (de)
AU (1) AU2003296045B2 (de)
BR (1) BR0316086A (de)
CA (1) CA2502416C (de)
CO (1) CO5570702A2 (de)
CY (1) CY1106957T1 (de)
DE (1) DE60316339T2 (de)
DK (1) DK1558580T3 (de)
ES (1) ES2293059T3 (de)
HR (1) HRP20050517B1 (de)
IL (1) IL168118A (de)
MA (1) MA27549A1 (de)
MX (1) MXPA05004897A (de)
NO (1) NO331012B1 (de)
NZ (1) NZ539385A (de)
PL (1) PL377176A1 (de)
PT (1) PT1558580E (de)
RU (1) RU2321584C2 (de)
WO (1) WO2004043928A2 (de)
ZA (1) ZA200503682B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
US20070275944A1 (en) * 2006-04-05 2007-11-29 The Board Of Trustees Operating Michigan State University Antioxidants and methods of their use
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
BRPI1006897A2 (pt) 2009-07-06 2015-09-08 Akebia Therapeutics Inc compostos, composições e métodos de prevenção da metástase de células cancerosas.
EP2649998B1 (de) * 2009-11-06 2015-03-04 Aerpio Therapeutics Inc. Prolylhydroxylasehemmer
EP3815685A3 (de) 2011-10-31 2021-10-13 The Methodist Hospital Research Institute Verbindung mit einem mao-targeting/seeker-teil zur behandlung von menschlichen gliomen
CN103360308A (zh) * 2012-03-28 2013-10-23 孙伟新 1,4-二羟基-6-甲基-2-吡啶酮类化合物及其制备方法和用途
MX371382B (es) 2013-03-15 2020-01-28 Aerpio Therapeutics Inc Composiciones, formulaciones y metodos para tratar enfermedades oculares.
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
ES2739625T3 (es) 2014-02-19 2020-02-03 Aerpio Therapeutics Inc Proceso para la preparación de N-bencil-3-hidroxi-4-sustituido-piridin-2-(1H)-onas
EP3116503A4 (de) 2014-03-14 2017-08-23 Aerpio Therapeutics, Inc. Hptp-beta-hemmer
WO2016022813A1 (en) 2014-08-07 2016-02-11 Aerpio Therapeutics, Inc. Combination of immunotherapies with activators of tie-2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853900A (en) 1973-09-14 1974-12-10 Searle & Co 4-benzyloxy-2 (1h)-pyridones
US5358949A (en) 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DE4316077A1 (de) 1993-05-13 1994-11-17 Bayer Ag Substituierte Mono- und Bihydridylmethylpyridone
US5789426A (en) 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones

Also Published As

Publication number Publication date
JP2006513164A (ja) 2006-04-20
HRP20050517A2 (en) 2005-12-31
NO331012B1 (no) 2011-09-05
CN1708482A (zh) 2005-12-14
NZ539385A (en) 2008-02-29
US20070238722A1 (en) 2007-10-11
US7247632B2 (en) 2007-07-24
MA27549A1 (fr) 2005-10-03
US6946479B2 (en) 2005-09-20
NO20052788L (no) 2005-06-09
ZA200503682B (en) 2006-11-29
AU2003296045B2 (en) 2008-04-03
WO2004043928A8 (en) 2005-05-06
EP1558580B1 (de) 2007-09-12
PL377176A1 (pl) 2006-01-23
CA2502416C (en) 2010-07-20
CA2502416A1 (en) 2004-05-27
JP4327730B2 (ja) 2009-09-09
WO2004043928A2 (en) 2004-05-27
KR20050055793A (ko) 2005-06-13
IL168118A (en) 2011-07-31
BR0316086A (pt) 2005-09-27
US20040097559A1 (en) 2004-05-20
CO5570702A2 (es) 2005-10-31
EP1558580A2 (de) 2005-08-03
WO2004043928A3 (en) 2004-07-01
US20050256126A1 (en) 2005-11-17
CY1106957T1 (el) 2012-09-26
KR20070030334A (ko) 2007-03-15
RU2321584C2 (ru) 2008-04-10
AU2003296045A1 (en) 2004-06-03
KR100894237B1 (ko) 2009-04-20
HRP20050517B1 (hr) 2014-03-14
ATE372986T1 (de) 2007-09-15
RU2005114490A (ru) 2006-01-20
PT1558580E (pt) 2007-12-06
ES2293059T3 (es) 2008-03-16
DK1558580T3 (da) 2008-01-14
MXPA05004897A (es) 2005-11-17
DE60316339T2 (de) 2008-06-05

Similar Documents

Publication Publication Date Title
DE60316338D1 (de) N-alkyl-4-methylenamino-3-hydroxy-2-pyridone verwendbar als antimikrobielle mittel
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DE60131138D1 (de) Antibakterielle mittel
ECSP003699A (es) Inhibidores de fab i
ATE420639T1 (de) Antimykotische mittel
ATE516022T1 (de) Antimikrobielle zusammensetzungen und anwendungsverfahren dafür
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
NO20062629L (no) Oksazolderivater av tetrackliner
ATE433963T1 (de) Fab-i inhibitoren
DK1709044T3 (da) Oxazolidinon-quinolon-hybridantibiotika
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BG108498A (en) New derivatives of oxazolidinones as antibacterial agents
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
MXPA06000372A (es) Compuestos de silicio y su uso.
NO20053562L (no) Nye aminobenzofenonforbindelser
BRPI0412360A (pt) compostos de organossilìcio e seu uso
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase
ATE364037T1 (de) Tryptasehemmer
EA200501830A1 (ru) Новые производные линкомицина, обладающие антимикробной активностью
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
FI20020507A0 (fi) Antimikrobiaine patogeenisia bakteereita vastaan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WARNER CHILCOTT COMPANY, LLC, FAJARDO, P.R., US